Alerts will be sent to your verified email
Verify EmailVENUSREM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Venus Remedies Limited is an Indian pharmaceutical company with a global presence, specializing in critical care and super specialty segments. It is dedicated to research, innovation, and delivering high-quality products worldwide.
Venus Remedies major competitors are Jenburkt Pharma, Prevest Denpro, Medicamen Biotech, Zim Laboratories, Ind-Swift Lab., Albert David, Kilitch Drugs(India).
Market Cap of Venus Remedies is ₹578 Crs.
While the median market cap of its peers are ₹567 Crs.
Venus Remedies seems to be less financially stable compared to its competitors.
Altman Z score of Venus Remedies is 5.16 and is ranked 5 out of its 8 competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | Mar Sep | Mar Sep Dec | ||||||||||||||||
Conference Call | ||||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|